Sars-Cov 2 versus Flu: ECMO-associated bloodstream infections

SARS-CoV-2 and flu may lead to severe acute respiratory distress syndrome (ARDS) requiring extracorporeal membrane oxygenation (ECMO). The aim of the present study is to compare the incidence of bloodstream infections (BSIs) and outcome in patients with flu and SARS-CoV-2 infection hospitalized in I...

Full description

Saved in:
Bibliographic Details
Published inThe New microbiologica Vol. 45; no. 1; pp. 35 - 39
Main Authors Roda, Silvia, Seminari, Elena, Pieri, Teresa C, Sachs, Michele, Di Matteo, Angela M, Belliato, Mirko, Corbella, Marta, Degani, Antonella, Piralla, Antonio, Bruno, Raffaele
Format Journal Article
LanguageEnglish
Published Italy Edizioni Medico Scientifiche 01.01.2022
Subjects
COVID-19
Extracorporeal Membrane Oxygenation
Humans
Infections
Influenza
Middle Aged
Mortality
Oxygenation
Public health
Respiratory distress syndrome
Retrospective Studies
SARS-CoV-2
Sepsis
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
ECMO
bloodstream infections
SARS-CoV-2
flu
Online AccessGet full text

Cover

More Information
Summary:SARS-CoV-2 and flu may lead to severe acute respiratory distress syndrome (ARDS) requiring extracorporeal membrane oxygenation (ECMO). The aim of the present study is to compare the incidence of bloodstream infections (BSIs) and outcome in patients with flu and SARS-CoV-2 infection hospitalized in ICU and undergoing ECMO. This study is a retrospective analysis of the San Matteo COVID-19 Registry (SMACORE) cohort. The study was conducted from January 2018 to April 2020. Demographic data and microbiological data were recorded during hospitalization. BSIs occurring during ECMO were analyzed. Eighteen patients treated with ECMO, 22 subjects with SARS-CoV-2 infection and 7 with flu, median age 61years for SARS-CoV-2 and 50 for flu (p=NS). Median ECMO duration was similar in the two pathologies. Median time to bloodstream infection from ECMO initiation was similar. Bloodstream infection incidence rate was 2.65 per 100 patients/days for flu and 2.2 per 100 patients/days for SARS-CoV-2. Global infection rate was 5 per 100 patients/days for SARS-CoV-2 patients and 5.3 per 100 patients/days for flu. Mortality during ECMO was 40.9% (5 out of 22 patients) for SARS-CoV-2 infection while none died among flu patients. ECMO-associated mortality was higher in SARS-CoV-2 infection compared with flu infection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1121-7138